Navina Named One of New York’s Top 10 Funded Healthcare Companies for Q1 2025

Navina, a Grove Ventures portfolio company, has been recognized as one of the Top 10 Funded Healthcare Companies in New York for Q1 2025 by Digital Health New York (DHNY). Moreover, this distinction, featured in the Q1 2025 New York Healthcare Innovation Report, spotlights the companies driving significant advancement and investment momentum in the healthcare sector.

A Major Milestone Following Navina’s $55M Series C Round

This recognition follows Navina’s recent $55 million Series C funding round, a milestone that underscores the company’s growing influence and success in the rapidly evolving field of clinical intelligence. While Navina’s platform empowers primary care physicians by delivering AI-powered insights that help manage patient complexity, it also reduces administrative burden, and improves clinical decision-making at the point of care.

With its continued growth, Navina is not only attracting investor confidence but also proving its ability to reshape healthcare delivery models through scalable, intelligent infrastructure for value-based care.

Transforming Healthcare Through Clinical Intelligence

Navina’s inclusion in DHNY’s list highlights its role as a category-defining company in health tech, as one that blends data science, machine learning, and a deep understanding of the healthcare system to support better outcomes for patients and providers alike.

Read the full report from Digital Health New York here.

At Grove Ventures, we are proud to partner with companies like Navina that are transforming healthcare through actionable intelligence and innovation.